These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 28369307)

  • 21. Drug-resistant tuberculosis: resistance mechanisms and rapid susceptibility testing.
    Pfyffer GE
    Schweiz Med Wochenschr; 2000 Dec; 130(49):1909-13. PubMed ID: 11153397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of molecular genetic methods in macrolide, lincosamide and streptogramin resistance diagnostics and in detection of drug-resistant Mycobacterium tuberculosis.
    Jalava J; Marttila H
    APMIS; 2004; 112(11-12):838-55. PubMed ID: 15638840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic diversity of Mycobacterium tuberculosis in Madang, Papua New Guinea.
    Ballif M; Harino P; Ley S; Carter R; Coulter C; Niemann S; Borrell S; Fenner L; Siba P; Phuanukoonnon S; Gagneux S; Beck HP
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1100-7. PubMed ID: 22710686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates.
    Brandis G; Hughes D
    J Antimicrob Chemother; 2013 Nov; 68(11):2493-7. PubMed ID: 23759506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA Replication Fidelity in the Mycobacterium tuberculosis Complex.
    Warner DF; Rock JM; Fortune SM; Mizrahi V
    Adv Exp Med Biol; 2017; 1019():247-262. PubMed ID: 29116639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
    Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
    J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of drug resistance in Mycobacterium tuberculosis.
    Zhang Y; Yew WW
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A proportion of mutations fixed in the genomes of in vitro selected isogenic drug-resistant Mycobacterium tuberculosis mutants can be detected as minority variants in the parent culture.
    Bergval I; Coll F; Schuitema A; de Ronde H; Mallard K; Pain A; McNerney R; Clark TG; Anthony RM
    FEMS Microbiol Lett; 2015 Jan; 362(2):1-7. PubMed ID: 25670707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mycobacterium tuberculosis mutants with multidrug resistance: history of origin, genetic and molecular mechanisms of resistance, and emerging challenges].
    Prozorov AA; Zaĭchikova MV; Danilenko VN
    Genetika; 2012 Jan; 48(1):5-20. PubMed ID: 22567849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis.
    Shcherbakov D; Akbergenov R; Matt T; Sander P; Andersson DI; Böttger EC
    Mol Microbiol; 2010 Aug; 77(4):830-40. PubMed ID: 20545852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.
    Gagneux S; Long CD; Small PM; Van T; Schoolnik GK; Bohannan BJ
    Science; 2006 Jun; 312(5782):1944-6. PubMed ID: 16809538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis isolates in Sichuan, China and the association between Beijing-lineage and dual-mutation in gidB.
    Sun H; Zhang C; Xiang L; Pi R; Guo Z; Zheng C; Li S; Zhao Y; Tang K; Luo M; Rastogi N; Li Y; Sun Q
    Tuberculosis (Edinb); 2016 Jan; 96():102-6. PubMed ID: 26786661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland].
    Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z
    Pneumonol Alergol Pol; 2010; 78(4):256-62. PubMed ID: 20665445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterial diversity causing multi- and extensively drug-resistant tuberculosis in Djibouti, Horn of Africa.
    Millán-Lou MI; Ollé-Goig JE; Tortola MT; Martin C; Samper S
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):150-3. PubMed ID: 26792464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of genes associated with drug resistance in Mycobacterium tuberculosis strains isolated in Chile].
    Araya P; Velasco M; Tognarelli J; Arias F; Leiva T; Sccapatticio A; Alviz P; Fernández J
    Rev Med Chil; 2011 Apr; 139(4):467-73. PubMed ID: 21879185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of
    Nimmo C; Millard J; Faulkner V; Monteserin J; Pugh H; Johnson EO
    Front Cell Infect Microbiol; 2022; 12():954074. PubMed ID: 36275027
    [No Abstract]   [Full Text] [Related]  

  • 38. Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis.
    Victor TC; Warren R; Butt JL; Jordaan AM; Felix JV; Venter A; Sirgel FA; Schaaf HS; Donald PR; Richardson M; Cynamon MH; Van Helden PD
    J Med Microbiol; 1997 Oct; 46(10):847-57. PubMed ID: 9364141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative molecular study of Mycobacterium tuberculosis strains, in times of antimicrobial drug resistance.
    Varela G; Carvajales S; Gadea P; Sirok A; Grotiuz G; Mota MI; Ritacco V; Reniero A; Rivas C; Schelotto F
    Rev Argent Microbiol; 2005; 37(1):11-5. PubMed ID: 15991474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classical against molecular-genetic methods for susceptibility testing of antituberculotics.
    Porvaznik I; Mokry J; Solovic I
    Adv Exp Med Biol; 2015; 835():15-22. PubMed ID: 25252893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.